Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
autologous cd34+ cells transduced with wasp lentiviral vector (1 trial)
autologous cd34 positive cells transduced with a lentiviral vector containing human was gene (2 trials)
gnt0003 (1 trial)
lentiviral g1xcgd (1 trial)
valproic acid (depakene) (1 trial)
x vivo gene therapy (2 trials)
Cardiomyopathies (Phase 2)
Crigler-Najjar Syndrome (Phase 2)
Granuloma (Phase 2)
Granulomatous Disease, Chronic (Phase 2)
Syndrome (Phase 2)
Wiskott-Aldrich Syndrome (Phase 2)
Trials (8 total)
Trial APIs (6 total)